Measurement of skin data of hyperpigmentation caused by chemotherapy with pyrimidine fluoride-derived anticancer agent for development of a medical cover foundatio
Not Applicable
- Conditions
- gastric cancer, colorectal cancer and esophageal cancer
- Registration Number
- JPRN-UMIN000022748
- Lead Sponsor
- ational Cancer Center Hospital, Appearance Support Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who are unable to respond to self-completed questionnaires. 2) Patients who are judged inappropriate for participate in this study by physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <Assessment by devices> 1) Optical properties (absorption and scattering coefficients) 2) Spectral reflectivity 3) Visia (Facial skin condition) 4) Epidermal and dermal water content <Self-completed questionnaires> Appearance-related distress
- Secondary Outcome Measures
Name Time Method